151 related articles for article (PubMed ID: 29044221)
1. Downregulation of miR-16 via URGCP pathway contributes to glioma growth.
Hong L; Qing O; Ji Z; Chengqu Z; Ying C; Hao C; Minhui X; Lunshan X
Sci Rep; 2017 Oct; 7(1):13470. PubMed ID: 29044221
[TBL] [Abstract][Full Text] [Related]
2. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
3. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.
Hui W; Yuntao L; Lun L; WenSheng L; ChaoFeng L; HaiYong H; Yueyang B
PLoS One; 2013; 8(1):e54932. PubMed ID: 23383003
[TBL] [Abstract][Full Text] [Related]
5. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
6. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.
Yu G; Zhang T; Jing Y; Bao Q; Tang Q; Zhang Y
Life Sci; 2017 Apr; 175():47-51. PubMed ID: 28315691
[TBL] [Abstract][Full Text] [Related]
7. URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway.
Cai J; Li R; Xu X; Zhang L; Wu S; Yang T; Fang L; Wu J; Zhu X; Li M; Huang Y
Oncotarget; 2015 Nov; 6(34):36489-504. PubMed ID: 26429875
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
9. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.
Dodurga Y; Gundogdu G; Tekin V; Koc T; Satiroglu-Tufan NL; Bagci G; Kucukatay V
Mol Biol Rep; 2014 Jul; 41(7):4595-9. PubMed ID: 24652203
[TBL] [Abstract][Full Text] [Related]
11. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
[TBL] [Abstract][Full Text] [Related]
14. MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells.
Sun G; Shi L; Yan S; Wan Z; Jiang N; Fu L; Li M; Guo J
Biomed Res Int; 2014; 2014():687826. PubMed ID: 24995320
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.
Tang Z; Fang Y; Du R
Biochem Biophys Res Commun; 2019 Apr; 512(2):331-337. PubMed ID: 30885433
[TBL] [Abstract][Full Text] [Related]
17. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
18. A novel oncogene URG4/URGCP and its role in cancer.
Dodurga Y; Seçme M; Lale Şatıroğlu-Tufan N
Gene; 2018 Aug; 668():12-17. PubMed ID: 29775749
[TBL] [Abstract][Full Text] [Related]
19. Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner.
Wang G; Sai K; Gong F; Yang Q; Chen F; Lin J
Mol Med Rep; 2014 May; 9(5):1799-805. PubMed ID: 24626950
[TBL] [Abstract][Full Text] [Related]
20. TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.
Song L; Liu L; Wu Z; Li Y; Ying Z; Lin C; Wu J; Hu B; Cheng SY; Li M; Li J
J Clin Invest; 2012 Oct; 122(10):3563-78. PubMed ID: 23006329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
